深度学习驱动的de novo药物设计基于胃质子结构
Kazuhiro Abe1,2,3, Mami Ozako4, Miki Inukai4
1Cellular and Structural Physiology Institute, Nagoya University, Nagoya, Aichi, 464-8601, Japan. kabe@cespi.nagoya-u.ac.jp.
研究人员使用人工智能驱动的药物设计和冷EM开发了针对胃质子的新型化合物. 最强效的化合物,DQ-18,对新药开发具有强大的抑制潜力.
科学领域:
- 药用化学 医学化学
- 结构生物学 结构生物学
- 计算机化药物发现技术
背景情况:
- 现有的药物面临着诸如副作用和较差的结合亲和力等局限性.
- 针对胃质子对于治疗的发展至关重要.
研究的目的:
- 设计新型化合物,对胃质子具有很高的抑制作用.
- 通过基于结构的de novo设计,克服现有药物的局限性.
主要方法:
- 使用深度生成模型进行新药设计 (深度四重奏工作流).
- 使用有机合成和冷电子显微镜 (cryo-EM) 进行结构分析.
- 集成的in silico设计与体外查和结构验证.
主要成果:
- 设计和合成基于与药物结合的质子药的候选化合物.
- 确定了DQ-18 (N-甲基-4-((2-(基)-5-基) 氧) 胺) 作为最强效的化合物.
- 获得DQ-18的Ki值为47.6nM,绑定姿势由2.08 Å的冷EM确定.
结论:
- 综合方法使得基于结构的新药开发成为可能.
- 高分辨率的冷EM可方便代化合物设计和优化.
- 证明了一个成功的框架,用于创建针对特定蛋白质结构的强效药物候选物.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drug Discovery: Overview
